• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反应性增殖和弥漫性特发性肺神经内分泌细胞增生(DIPNECH)中肺神经内分泌细胞的形态和抗原表达谱。

Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

机构信息

Department of Pathology, Royal Liverpool University Hospital University of Liverpool, UK.

出版信息

Histopathology. 2011 Oct;59(4):751-62. doi: 10.1111/j.1365-2559.2011.03992.x.

DOI:10.1111/j.1365-2559.2011.03992.x
PMID:22014055
Abstract

AIMS

To compare the morphology and antigenic profile of pulmonary neuroendocrine cells (PNECs) proliferating as a reaction to pulmonary injury with those proliferating in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in which carcinoids develop.

METHODS AND RESULTS

The morphology and expression of a range of antigens including markers of epithelial differentiation [cytokeratins, thyroid transcription factor (TTF)-1], neuroendocrine antigens [neural cell adhesion molecule (NCAM), chromogranin, protein gene product (PGP) 9.5, neurone-specific enolase (NSE), synaptophysin], peptide products [gastrin-releasing peptide (GRP), calcitonin, calcitonin gene-related peptide (CGRP)] and inactivator [common acute lymphoblastic leukaemia antigen (CALLA)] and antigens involved in cell proliferation and death (p53, p16, p27, Rb, Bcl-2, c-kit, Ki67) were studied in four cases of reactive PNEC proliferation and seven cases of DIPNECH. Proliferation was more florid in DIPNECH. There was no major shift in antigen expression with proliferation in either group apart from CALLA, which was expressed only by proliferating cells and not by solitary PNECs. There were differences between the groups in expression of p53, p16 and Ki67, which were seen more consistently and earlier in proliferation in DIPNECH.

CONCLUSIONS

These data suggest that there are early and fundamental differences in cell kinetics between the reactive PNEC proliferation that occurs in response to pulmonary injury and that seen in the pre-neoplastic condition of DIPNECH.

摘要

目的

比较作为肺损伤反应而增殖的肺神经内分泌细胞(PNEC)与在弥漫性特发性肺神经内分泌细胞增生(DIPNECH)中增殖的形态和抗原表型,后者发生类癌。

方法和结果

研究了 4 例反应性 PNEC 增殖和 7 例 DIPNECH 中一系列抗原的形态和表达,包括上皮分化标志物[细胞角蛋白、甲状腺转录因子(TTF)-1]、神经内分泌抗原[神经细胞黏附分子(NCAM)、嗜铬粒蛋白、蛋白基因产物(PGP)9.5、神经元特异性烯醇化酶(NSE)、突触素]、肽产物[胃泌素释放肽(GRP)、降钙素、降钙素基因相关肽(CGRP)]和失活剂[共同急性淋巴细胞白血病抗原(CALLA)]以及参与细胞增殖和死亡的抗原(p53、p16、p27、Rb、Bcl-2、c-kit、Ki67)。在 DIPNECH 中,增殖更为明显。除了 CALLA 之外,两组中增殖的抗原表达没有明显的变化,而 CALLA 仅表达于增殖细胞,而不表达于单个 PNEC。两组之间在 p53、p16 和 Ki67 的表达上存在差异,在 DIPNECH 的增殖中,这些差异更为一致且更早出现。

结论

这些数据表明,在对肺损伤的反应性 PNEC 增殖和 DIPNECH 的癌前状态中,细胞动力学存在早期和根本的差异。

相似文献

1
Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).反应性增殖和弥漫性特发性肺神经内分泌细胞增生(DIPNECH)中肺神经内分泌细胞的形态和抗原表达谱。
Histopathology. 2011 Oct;59(4):751-62. doi: 10.1111/j.1365-2559.2011.03992.x.
2
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.弥漫性特发性肺神经内分泌细胞增生和相关肺神经内分泌肿瘤:罕见实体的临床经验。
Cancer. 2012 Feb 1;118(3):612-9. doi: 10.1002/cncr.26200. Epub 2011 Jul 12.
3
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)。
Semin Diagn Pathol. 2015 Nov;32(6):438-44. doi: 10.1053/j.semdp.2015.08.002. Epub 2015 Sep 1.
4
[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (dipnech) - an overview of the cases diagnosed at the department of thoracic surgery in the years 2010-2014].[弥漫性特发性肺神经内分泌细胞增生(DIPNECH)——2010 - 2014年胸外科确诊病例概述]
Wiad Lek. 2017;70(5):1005-1012.
5
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)综合征与类癌肿瘤伴/不伴 NECH:一项临床病理、放射学和免疫分子比较研究。
Am J Surg Pathol. 2018 May;42(5):646-655. doi: 10.1097/PAS.0000000000001033.
6
Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).发育性神经转录因子在弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)中的表达
Virchows Arch. 2016 Sep;469(3):357-63. doi: 10.1007/s00428-016-1962-5. Epub 2016 Jun 14.
7
Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)小灶与肺癌腺癌的相关性。
Pathol Res Pract. 2013 Sep;209(9):578-84. doi: 10.1016/j.prp.2013.06.019. Epub 2013 Jul 12.
8
The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?多灶性肺神经内分泌增生的成人患者的病变谱:诊断弥漫性特发性肺神经内分泌细胞增生症的最小病理标准集是什么?
Hum Pathol. 2015 Feb;46(2):176-81. doi: 10.1016/j.humpath.2014.10.019. Epub 2014 Nov 12.
9
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a report of two cases.弥漫性特发性肺神经内分泌细胞增生症:两例报告
Pathol Int. 2010 Jul;60(7):538-41. doi: 10.1111/j.1440-1827.2010.02552.x.
10
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)与生长抑素类似物的作用:病例系列
Lung. 2015 Oct;193(5):653-7. doi: 10.1007/s00408-015-9754-2. Epub 2015 Jun 26.

引用本文的文献

1
Coexistence of DIPNECH with pulmonary adenocarcinoma: Coincidence or by design?弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)与肺腺癌并存:巧合还是有内在联系?
Heliyon. 2024 Oct 15;10(20):e39406. doi: 10.1016/j.heliyon.2024.e39406. eCollection 2024 Oct 30.
2
The challenge of diagnosing neuroendocrine neoplasms: experience from a national reference center.神经内分泌肿瘤的诊断挑战:来自国家参考中心的经验
Virchows Arch. 2024 Dec;485(6):1021-1031. doi: 10.1007/s00428-024-03957-8. Epub 2024 Oct 29.
3
Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria.
弥漫性特发性肺神经内分泌细胞增生症诊断标准的制定与验证
JTO Clin Res Rep. 2020 Jul 24;1(4):100078. doi: 10.1016/j.jtocrr.2020.100078. eCollection 2020 Nov.
4
A 68-year-old woman with a diagnosis of asthma and multiple fleeting pulmonary nodules- a case report.一名诊断为哮喘和多发短暂性肺结节的68岁女性——病例报告。
Respir Med Case Rep. 2020 Nov 12;31:101250. doi: 10.1016/j.rmcr.2020.101250. eCollection 2020.
5
[Systemic Therapy for Low-grade Pulmonary Neuroendocrine Tumor].[低级别肺神经内分泌肿瘤的系统治疗]
Zhongguo Fei Ai Za Zhi. 2019 Jan 20;22(1):34-39. doi: 10.3779/j.issn.1009-3419.2019.01.07.
6
A Rare Case of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia.弥漫性特发性肺神经内分泌细胞增生症一例罕见病例
Cureus. 2018 Apr 24;10(4):e2525. doi: 10.7759/cureus.2525.
7
Update on large cell neuroendocrine carcinoma.大细胞神经内分泌癌的最新进展。
Transl Lung Cancer Res. 2017 Oct;6(5):530-539. doi: 10.21037/tlcr.2017.06.12.
8
Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).发育性神经转录因子在弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)中的表达
Virchows Arch. 2016 Sep;469(3):357-63. doi: 10.1007/s00428-016-1962-5. Epub 2016 Jun 14.
9
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH):当前最佳证据
Lung. 2015 Oct;193(5):659-67. doi: 10.1007/s00408-015-9755-1. Epub 2015 Jun 24.
10
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.弥漫性特发性肺神经内分泌细胞增生症伴中央型和周边型类癌及多发肿瘤:强调神经肽激素和人绒毛膜促性腺激素-α作用的 1 例报告
Endocr Pathol. 2013 Dec;24(4):220-8. doi: 10.1007/s12022-013-9265-8.